Newsroom
Stay up to date with the latest REVERSE-IT trial newsletters, webinars, and press releases.
Intended for Healthcare Professionals
Stay up to date with the latest REVERSE-IT trial newsletters, webinars, and press releases.
September 16, 2021
July 2021 Monthly Site Webex
July 15, 2021
April 2021 Monthly Site Webex
April 22, 2021
March 2021 Monthly Site Webex
March 18, 2021
February 2021 Monthly Site Webex
February 18, 2021
December 2020 Monthly Site Webex
January 21, 2021
November 2020 Monthly Site Webex
November 24, 2020
January 2020 Monthly Site Webex
January 21, 2020
PhaseBio Announces Interim Analysis of REVERSE-IT Phase 3 Trial Accepted for Late Breaking Science Presentation at the American Heart Association Scientific Sessions 2021
October 06, 2021
PhaseBio Pharmaceuticals Achieves Enrollment Milestones Supporting Interim Analysis of REVERSE-IT Global Phase 3 Trial, Enabling Preparation of a BLA submission for Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor
August 12, 2021
PhaseBio Announces Dosing of First Patient in European Union as Part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor
January 28, 2021